肝硬化顽固性腹水的治疗进展  

Treatment progress of liver cirrhosis refractory ascites

作　　者：王爱军[1] 刘茗[1] 

机构地区：[1]河北省廊坊市人民医院消化内科,河北廊坊065000

出　　处：《中国当代医药》2013年第36期22-23,共2页China Modern Medicine

基　　金：河北省廊坊市科技计划项目(2010013021)

摘　　要：肝硬化失代偿期患者可发生严重的水电解质平衡失调,主要表现为腹水和水肿。晚期肝硬化患者因严重的尿钠潴留可进展为肝硬化顽固性腹水(RA)。RA是指药物治疗不能消退或经排放腹水等治疗后用药物不能有效防止近期复发的腹水。RA是临床医师工作中经常遇到的难题,不仅增加患者的痛苦,且易引起多种并发症,治疗难度大,危险性高。临床上多采用限钠、限水、保肝、利尿、腹腔穿刺放腹水、补充清蛋白等综合治疗,本文将目前临床常用的治疗方法进行综述,为给基层临床治疗提供参考。Serious water-electrolyte imbalance could happen in patients with decompensated cirrhosis, it mainly man- ifest as ascites and edema. Due to severe urinary sodium retention, patients with advanced cirrhosis could progress into liver cirrhosis refractory ascites （RA）. RA refers to those ascites which could not fade after drug treatment or the short term recurrence of ascites could not be effectively prevented after drug treatment. RA is an often encountered clinician in clinical work. It not only increase pain of patients, but also cause multiple complications easily. The treatment has significant difficulty and high risk. Comprehensive treatment is generally used in clinic, including sodium and water restriction, liver protection, diuresis, peritonrocentesis, and albumin supplementation, etc.This article reviews common methods used in clinic, in order to provide reference for primary treatment.

关 键 词：肝硬化 顽固性腹水 临床治疗 

分 类 号：R657.31[医药卫生—外科学]